Physician profile
Robert R Grant
NPI 1790897908
$4,377.00
in general payments reported to CMS, 2019-2025
25 companies · $547 in 2025
The $547 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $33.55 · 2021: $393 · 2022: $1,276 · 2023: $775 · 2024: $780 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,101.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,660.70 | 2021-2025 | Resolute Onyx, Corevalve Evolut R, Linq II |
| Abiomed | $598.51 | 2019-2024 | Impella |
| Edwards Lifesciences Corporation | $275.61 | 2019-2023 | Sapien 3 Ultra Resilia |
| Heartflow, INC. | $256.94 | 2022 | |
| Biotronik INC. | $249.52 | 2019-2025 | Amvia Edge, Selectra, Solia |
| Amgen INC. | $246.22 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $176.14 | 2022-2025 | |
| Boston Scientific Corporation | $111.48 | 2021-2025 | Watchman Access System, Watchman Flx |
| Cardiva Medical, INC. | $106.65 | 2023-2025 | Savvywire, Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Medtronic Vascular, INC. | $96.23 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.23 | 2024-2025 | Lifevest |
| Abbott Laboratories | $78.07 | 2022-2024 | Jot Dx |
| Penumbra, INC. | $67.77 | 2023-2025 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $64.14 | 2024-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $56.17 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $40.66 | 2022 | |
| Shockwave Medical, INC | $36.66 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $32.06 | 2024 | Perclot |
| Sanofi-Aventis U.S. LLC | $25.29 | 2019-2021 | |
| Biosense Webster, INC. | $22.87 | 2024 | Qdot Micro Catheter |
| Altathera Pharmaceuticals LLC | $18.66 | 2023 | Sotalol Hydrochloride |
| Janssen Pharmaceuticals, INC | $17.79 | 2023 | Xarelto |
| Lundbeck LLC | $16.34 | 2019 | |
| Merck Sharp & Dohme LLC | $13.21 | 2022 | |
| Novartis Pharmaceuticals Corporation | $13.08 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.